PTGX — Protagonist Therapeutics, Inc. | XLV Holdings | StockAdder

(PTGX)

Protagonist Therapeutics, Inc.

Live chart and latest PTGX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

PTGX News

Truist raises Protagonist Therapeutics stock price target on Icotyde outlook

Apr 14, 2026 Yahoo Finance

Is Protagonist Therapeutics (PTGX) Still Attractive After A 133% One-Year Share Price Surge

Apr 3, 2026 ChartMill

PTGX Stock Price, Quote & Chart | PROTAGONIST THERAPEUTICS INC (NASDAQ:PTGX)

Apr 9, 2026 MarketBeat

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives Consensus Rating of "Moderate Buy" from Analysts

Apr 10, 2026 Investing.com

Protagonist Therapeutics stock hits all-time high at 105.71 USD

Mar 31, 2026 MarketBeat

Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) Director Sells 24,000 Shares of Stock

Mar 28, 2026 Yahoo Finance

Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

Mar 20, 2026 Yahoo Finance

Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?

Mar 27, 2026 MarketBeat

Dinesh Ph Patel Sells 54,641 Shares of Protagonist Therapeutics (NASDAQ:PTGX) Stock

Mar 25, 2026 Investing.com

Protagonist Therapeutics PTGX: Ali Asif sells $2.58 million in stock

Mar 27, 2026 Yahoo Finance

Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

Oct 10, 2025 MarketBeat

Arturo Md Molina Sells 15,000 Shares of Protagonist Therapeutics (NASDAQ:PTGX) Stock

Mar 28, 2026 Yahoo Finance

Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

Mar 20, 2026 MarketBeat

Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells $2,581,503.60 in Stock

Mar 28, 2026 Yahoo Finance

Is It Too Late To Consider Protagonist Therapeutics (PTGX) After Its 119% One-Year Surge?